Table 1 Characteristics of patients
From: QTc and psychopharmacs: are there any differences between monotherapy and polytherapy
Group 1 (N = 32) | Group 2 (N = 29) | ||
|---|---|---|---|
Characteristic | Patients in monotherapy | Patients in polytherapy | *p |
Age, range (yr) | 27–69 | 27–70 | |
Age, mean ± SD (yr) | 48.3 ± 8.8 | 48.6 ± 11.3 | 0.771 |
Duration of illness, mean ± SD (yr) | 10.8 ± 7.3 | 10.7 ± 9.1 | 0.950 |
BMI, mean ± SD | 25.1 ± 5.5 | 27.9 ± 5.5 | 0.059 |
**p | |||
Smoking present, N (%) | 16 (50.0) | 15 (51.7) | 1.000 |
Applied dose > DDD: | |||
Dose of AP > DDD, N (%) | 7 (21.9) | 8 (27.6) | 0.767 |
Dose of AD > DDD, N (%) | 9 (28.1) | 11 (37.9) | 0.586 |